Clinical Trial Update: KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for KN046 in late-stage esophageal squamous cell carcinoma has completed enrollment and results are likely to be reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• KN046

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED